Suven gets product patents in China, Sri Lanka

New Delhi, Jan 18 (PTI) Suven Life Sciences has secured aproduct patent each from China and Sri Lanka corresponding tothe new chemical entities (NC...

New Delhi, Jan 18 (PTI) Suven Life Sciences has secured aproduct patent each from China and Sri Lanka corresponding tothe new chemical entities (NCEs) for the treatment ofdisorders associated with neurodegenerative diseases.

The two patents are valid through 2033 and 2032,respectively, the company said in a BSE filing.

"We are pleased by the grant of these patents to Suvenfor our pipeline of molecules in the central nervoussystem (CNS) arena, which are being developed for cognitivedisorders with high unmet medical need with a huge marketpotential globally," Suven Life CEO Venkat Jasti said.

According to the company, the granted claims of thepatents are being developed as therapeutic agents and areuseful in treatment of cognitive impairment associated withneurodegenerative disorders like Alzheimer's disease,Parkinson and Schizophrenia.

The stock was trading 2.42 per cent higher at Rs 209.10on BSE. PTI SVK ANSMR.

This is unedited, unformatted feed from the Press Trust of India wire.

Related Stories

No stories found.
The New Indian Express
www.newindianexpress.com